Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107726 · ClinicalTrials.gov registry record · NA
Family Based Time-Restricted Eating
A NA study of Childhood Obesity, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT05107726: Completed NA study of Childhood Obesity, sponsored by University of Minnesota.
NCT05107726 is a NA study of Childhood Obesity that has completed, run by University of Minnesota. The registered enrollment target is 43 participants, below the 560-participant average among 43 other Childhood Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107726, a NA study of Childhood Obesity, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test whether managing the hours during which people eat, called time restricted eating, might help them to lose weight. For this study, one parent and a child will enroll as a group (called a dyad). The dyads will be assigned at random to practice time restricted eating (within 10-12 hours per day) but will be able to eat whatever they would like or to limit portion size and increase fruit, vegetable and lean protein intake and limit sugar sweetened beverages and undergo . Both groups will receive dietary counseling, Bluetooth toothbrushes and scales to help monitor their progress. The study will last for 12 weeks and will have one survey four weeks after the last in person visit. There will be 2 in person visits, 7 virtual visits, 2 phone visits and daily time logs.
Primary Outcome
Change in baseline BMI (kg/m\^2) among pediatric participants.
Conditions Studied
Interventions
- BEHAVIORAL TRE Group
Study Locations (1)
Minnesota
- University of Minnesota, Delaware Clinical Research Unit - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2022-03-30 |
| Est. Completion | 2023-09-13 |
| Phase | NA |
What the finished NCT05107726 record still lists
NCT05107726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 560-participant average among 43 other Childhood Obesity trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Childhood Obesity appearing as the primary indexed condition, and to 1 intervention - of which TRE Group is the first listed.
NCT05107726 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05107726 about?
NCT05107726 is a clinical study titled "Family Based Time-Restricted Eating". This study will test whether managing the hours during which people eat, called time restricted eating, might help them to lose weight. For this study, one parent and a child will enroll as a group (called a dyad). The dyads will be assigned at random to practice time restricted eating (within 10-1...
What is the current status of trial NCT05107726?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2022-03-30. Estimated completion is 2023-09-13.
What conditions does trial NCT05107726 study?
This clinical trial studies the following conditions: Childhood Obesity.
What interventions are being tested in trial NCT05107726?
The interventions under investigation include: TRE Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05107726?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05107726 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05107726's enrollment target sits among peer trials
43 37th of 43 higher than 7 of 43 other Childhood Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Family Intervention to Prevent Childhood Obesity
RECRUITING · NA
-
Integrating Food Rx With Best Feeding Practices With EFNEP
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life
RECRUITING · NA
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
RECRUITING · NA
-
Mountain West Prevention Research Center Core Research Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI